Aktienanalyse zu Align Technology, Inc. (ALGN)ALGNAlign Technology, Inc.

Align Technology, Inc. is a global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for digital orthodontics and restorative dentistry. The Company provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The Company's non-case products include retention products, Invisalign training and adjusting tools. It offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Align Technology is currently not a strong buy due to its current price of $147.31 being below several analyst price targets, with the lowest target at $155 and the highest at $230. The stock has shown a 5-day change of +3.22%, indicating some recent positive momentum, but the overall year-to-date change is -5.59%, suggesting ongoing challenges. Additionally, the RSI is at 61.119, which is approaching overbought territory, indicating caution. The main risk is the declining consumer sentiment and weakening demand indicators, which could impact future earnings.

11 analysts cover ALGN: 11 rate it Buy, 0 Hold and 0 Sell. The average price target is 198.70.